Startups
Ascensia Diabetes Care is a global company dedicated to improving the lives of people with diabetes and helping empower them to take charge of their health and happiness. Our goal is to provide products and solutions that make a positive, daily difference for people with diabetes. We want to help make sure diabetes doesn’t get in the way of people’s future, enabling them to live richer lives.
At Ascensia Diabetes Care we want to serve the needs of patients through our innovation and specialized expertise in diabetes. We create high quality solutions and precision tools that help patients manage their condition and take charge of their lives. Innovation is in our DNA and we are agile, entrepreneurial and dynamic in the way we operate.
Ascensia Diabetes Care was established in 2016 through the acquisition of Bayer Diabetes Care by Panasonic Healthcare Holdings. We have been serving people with diabetes for over 70 years and our portfolio includes the world-renowned CONTOUR range of blood glucose monitoring systems. We are proud of our heritage as a leading provider of solutions for diabetes care. We are excited by what the future holds and will continue to build on the legacy of our longstanding commitment to diabetes.
At Ascensia Diabetes Care we want to serve the needs of patients through our innovation and specialized expertise in diabetes. We create high quality solutions and precision tools that help patients manage their condition and take charge of their lives. Innovation is in our DNA and we are agile, entrepreneurial and dynamic in the way we operate.
Ascensia Diabetes Care was established in 2016 through the acquisition of Bayer Diabetes Care by Panasonic Healthcare Holdings. We have been serving people with diabetes for over 70 years and our portfolio includes the world-renowned CONTOUR range of blood glucose monitoring systems. We are proud of our heritage as a leading provider of solutions for diabetes care. We are excited by what the future holds and will continue to build on the legacy of our longstanding commitment to diabetes.
Overview
Location
Switzerland, Basel-City, Basel
Employees
1001-5000
Founded date
2016
Mentions in press and media 16
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 11, 2026 | Ascensia Diabetes Care Partners With Sava And Leads Series B Financing | Ascensia Diabetes Care entered a strategic partnership with Sava Technologies to commercialize and distribute Sava’s wearable microsensor technology and led the company’s Series B financing. The partnership initially focuses on Europe. Asce... |
| Oct 9, 2026 | Ascensia Announces Strategic Partnership with Sava for Innovative Microsensor Technology | |
| Aug 6, 2026 | This Is the Moment Everything Changed: Ascensia Launches Global Art and Photography Competition for World Diabetes Day | Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TYO 6523), has launched its fifth annual This Is Diabetes Art & Photography Competition in support of World Diabetes Day 2026. This press... |
| Aug 5, 2026 | Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership | A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision cancer diagnostics solutions. NHS is the ... |
| Jun 1, 2026 | Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience | Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of CONTOUR®COMFORT pen needles, further strengthening its CONTOUR® portfolio with a solution that impro... |
| Feb 25, 2026 | Ascensia Diabetes Care Appoints Peter Bodlund as President and Chief Executive Officer | Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced the appointment of Peter Bodlund as President and Chief Executive Officer, effective April 1, 2026. He succeeds K... |
| Oct 2, 2024 | Ascensia Launches World’s First One-Year CGM System, Eversense® 365 | What You Should Know: – Ascensia Diabetes Care has announced the U.S. launch of the Eversense® 365 continuous glucose monitoring (CGM) system, an advancement in diabetes management. – Developed by Senseonics Holdings, Inc., Eversense 365 is... |
| Aug 8, 2024 | College Athlete Takes Diabetes in Stride | (NewsUSA) - Newly diagnosed college student Trevor Dixon shows that managing diabetes doesn’t get in the way of an active life at the transition to adulthood Trevor was in his second semester of his senior year in high school, when he found... |
| Mar 12, 2024 | SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS | Eligible individuals in the U.S. will pay $99 out of pocket for each 6-month CGM system, offering each year of continuous glucose monitoring for just $200* PARSIPPANY, N.J., March 12, 2024 /PRNewswire/ -- Ascensia Diabetes Care, a global di... |
Show more
Reviews 0
FAQ about Ascensia Diabetes Care
When was Ascensia Diabetes Care founded?
Ascensia Diabetes Care was founded in 2016.
What has the press written about Ascensia Diabetes Care?
Parsers VC has collected 16 articles mentioning Ascensia Diabetes Care, among them “Ascensia Diabetes Care Partners With Sava And Leads Series B Financing” (Oct 11, 2026) and “Ascensia Announces Strategic Partnership with Sava for Innovative Microsensor Technology” (Oct 9, 2026).
Is Ascensia Diabetes Care still active?
Yes, Ascensia Diabetes Care is active; its latest activity on Parsers VC dates from Oct 12, 2026.